Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BRVEBraveheart Bio, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | — | −$26.0M | — | −$0.51 | — | — | — | $1.3B |
| ANROAlto Neuroscience, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$25.0M | n/m | −$0.54 | n/m | — | — | $999M |
| IMTXImmatics N.V. | Healthcare | Nov 10 | Sep '26 | $7.8M | +40.0% | — | n/m | −$0.58 | n/m | — | — | $941M |
| KURAKura Oncology, Inc. | Healthcare | Nov 10 | Sep '26 | $23.0M | +9.5% | −$70.0M | n/m | −$0.78 | n/m | -326.9% | +58.6 pp | $688M |
| OLMAOlema Oncology, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$74.0M | n/m | −$0.73 | n/m | — | — | $633M |
| QUITAchieve Life Sciences, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$12.0M | n/m | −$0.11 | n/m | — | — | $630M |
| ABUSArbutus Biopharma Corporation | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | $59.0M | n/m | $0.30 | n/m | — | — | $621M |
| CGEMCullinan Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$49.0M | n/m | −$0.76 | n/m | — | — | $602M |
| OBIOOrchestra BioMed Holdings, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | −100.0% | −$19.0M | n/m | −$0.30 | n/m | — | — | $549M |
| AVRAnteris Technologies Global Corp. | Healthcare | Nov 10 | Sep '26 | $1.0M | n/m | −$27.0M | n/m | −$0.28 | n/m | — | — | $519M |
| CAPRCapricor Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$43.0M | n/m | −$0.73 | n/m | — | — | $487M |
| CARLCarlsmed, Inc. | Healthcare | Nov 10 | Sep '26 | $22.0M | +69.2% | −$12.0M | n/m | −$0.45 | n/m | -58.9% | +10.2 pp | $486M |
| EPRXEupraxia Pharmaceuticals Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$15.0M | n/m | −$0.23 | n/m | — | — | $445M |
| OVIDOvid Therapeutics Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$21.0M | n/m | −$0.10 | n/m | — | — | $419M |
| MASS908 Devices Inc. | Healthcare | Nov 10 | Sep '26 | $19.0M | +35.7% | −$5.0M | n/m | −$0.11 | n/m | -30.5% | +8.9 pp | $390M |
| IRDOpus Genetics, Inc. | Healthcare | Nov 10 | Sep '26 | $1.0M | n/m | −$46.0M | n/m | −$0.46 | n/m | — | — | $337M |
| PEPGPepGen Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$19.0M | n/m | −$0.28 | n/m | — | — | $269M |
| PLXProtalix BioTherapeutics, Inc. (DE) | Healthcare | Nov 10 | Sep '26 | $22.0M | +22.2% | $4.0M | +100.0% | $0.05 | +66.7% | 18.5% | +6.5 pp | $243M |
| IKTInhibikase Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$20.0M | n/m | −$0.10 | n/m | — | — | $194M |
| ELMDElectromed, Inc. | Healthcare | Nov 10 | Sep '26 | $19.0M | +11.8% | $3.0M | +50.0% | $0.32 | +28.0% | 18.7% | +2.9 pp | $189M |
| PALIPalisade Bio, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$15.0M | n/m | −$0.07 | n/m | — | — | $181M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$34.0M | n/m | −$0.43 | n/m | — | — | $156M |
| KRMDKORU Medical Systems, Inc. | Healthcare | Nov 10 | Sep '26 | $12.0M | +20.0% | $0.0M | n/m | $0.00 | n/m | 1.6% | +10.0 pp | $151M |
| TLSITriSalus Life Sciences, Inc. | Healthcare | Nov 10 | Sep '26 | $13.0M | +8.3% | −$9.0M | n/m | −$0.15 | n/m | -59.9% | +18.1 pp | $142M |
| HUMAHumacyte, Inc. | Healthcare | Nov 10 | Sep '26 | $1.0M | 0.0% | −$16.0M | n/m | −$0.06 | n/m | — | — | $139M |
| SIONSionna Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$32.0M | n/m | −$0.72 | n/m | — | — | $139M |
| MXCTMaxCyte, Inc. | Healthcare | Nov 10 | Sep '26 | $10.0M | +42.9% | −$5.0M | n/m | −$0.05 | n/m | -59.5% | +95.3 pp | $121M |
| UPBUpstream Bio, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$41.0M | n/m | −$0.75 | n/m | — | — | $115M |
| INOInovio Pharmaceuticals, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$49.0M | n/m | −$0.50 | n/m | — | — | $113M |
| XGNExagen Inc. | Healthcare | Nov 10 | Sep '26 | $18.0M | +5.9% | −$6.0M | n/m | −$0.25 | n/m | -23.9% | −6.0 pp | $96M |
| STXSStereotaxis, Inc. | Healthcare | Nov 10 | Sep '26 | $9.0M | +28.6% | −$6.0M | n/m | −$0.07 | n/m | -72.5% | +15.3 pp | $88M |
| CPIXCumberland Pharmaceuticals Inc. | Healthcare | Nov 10 | Sep '26 | $2.0M | n/m | $78.0M | n/m | $5.07 | n/m | -89.8% | — | $87M |
| BDTXBlack Diamond Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$10.0M | n/m | −$0.17 | n/m | — | — | $83M |
| SEERSeer, Inc. | Healthcare | Nov 10 | Sep '26 | $4.0M | 0.0% | −$14.0M | n/m | −$0.25 | n/m | -368.4% | +119.0 pp | $81M |
| COYACoya Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | −100.0% | −$11.0M | n/m | −$0.45 | n/m | — | — | $71M |
| GOSSGossamer Bio, Inc. | Healthcare | Nov 10 | Sep '26 | $38.0M | +192.3% | −$48.0M | n/m | −$7.36 | n/m | 18.7% | +388.2 pp | $68M |
| ATRAAtara Biotherapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $1.0M | −66.7% | −$2.0M | n/m | −$0.15 | n/m | -242.7% | −139.2 pp | $66M |
| PMVPPMV Pharmaceuticals, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$34.0M | n/m | −$0.52 | n/m | — | — | $65M |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$38.0M | n/m | −$1.81 | n/m | — | — | $62M |
| LNSRLENSAR, Inc. | Healthcare | Nov 10 | Sep '26 | $14.0M | 0.0% | −$5.0M | n/m | −$0.38 | n/m | -10.1% | +42.8 pp | $60M |
| BOLDBoundless Bio, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$5.0M | n/m | −$0.23 | n/m | — | — | $57M |
| XLOXilio Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $10.0M | −47.4% | −$6.0M | n/m | −$0.30 | n/m | -117.7% | −107.6 pp | $53M |
| IBIOiBio, Inc. | Healthcare | Nov 10 | Sep '26 | $1.0M | n/m | −$8.0M | n/m | −$0.05 | n/m | -775.6% | — | $53M |
| GANXGain Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$3.0M | n/m | −$0.07 | n/m | — | — | $50M |
| MDAISpectral AI, Inc. | Healthcare | Nov 10 | Sep '26 | $3.0M | −25.0% | −$4.0M | n/m | −$0.11 | n/m | -138.9% | −50.8 pp | $43M |
| HBIOHarvard Bioscience, Inc. | Healthcare | Nov 10 | Sep '26 | $22.0M | +4.8% | −$3.0M | n/m | −$0.58 | n/m | -5.2% | −6.1 pp | $42M |
| BMEABiomea Fusion, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$6.0M | n/m | −$0.09 | n/m | — | — | $35M |
| TELATELA Bio, Inc. | Healthcare | Nov 10 | Sep '26 | $19.0M | −9.5% | −$9.0M | n/m | −$0.16 | n/m | -38.5% | −1.9 pp | $34M |
| PRPOPrecipio, Inc. | Healthcare | Nov 10 | Sep '26 | $7.0M | +16.7% | $0.0M | n/m | $0.00 | n/m | 0.0% | +1.0 pp | $34M |
| KLRSKalaris Therapeutics, Inc. | Healthcare | Nov 10 | Sep '26 | $0.0M | n/m | −$11.0M | n/m | −$0.46 | n/m | — | — | $34M |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.